Aurobindo Pharma Expects to Commercialise Vaccine Facility by April-May 2021

The Hyderabad-based drug major is investing around Rs 275 crore on the facility which would be utilised to produce vaccines for the treatment of various viral diseases including COVID-19.

from Top Business News- News18.com https://ift.tt/3ocHnIR

• Tweet
• Share
• Share
• Share
• Share